Litigation Details for Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
✉ Email this page to a colleague
Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-01-21 |
| Court | District Court, D. Delaware | Date Terminated | 2019-09-27 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 6,713,446; 6,958,319 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-01-21 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2;. … 27 September 2019 1:14-cv-00093 830 Patent None District Court, D. Delaware | External link to document | |
| 2014-02-25 | 7 | enforceability of U.S. Patent Nos. 6,713,446 (the “’446 patent”) and 6,958,319 (the “’319 patent”). …United States Patent and Trademark Office (“PTO”), the PTO issued U.S. Patent No. 6,713,446 (“the ’446 … INFRINGEMENT OF U.S. PATENT NO. 6,713,446 28. Teva incorporates by reference…446 patent”) on or about March 30, 2004; that the ’446 patent is titled “Formulation of Boronic Acid Compounds…copy of the ’446 patent is attached to the Complaint as Exhibit A; and that the ’446 patent is owned by | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
